The DOI matches its OpenAlex record.
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Abstract
We conducted a controlled, blinded, multicenter study of disulfiram treatment of alcoholism in 605 men randomly assigned to 250 mg of disulfiram (202 men); 1 mg of disulfiram (204 men), a control for the threat of the disulfiram-ethanol reaction; or no disulfiram (199 men), a control for the counseling that all received. Bimonthly treatment assessments were done for one year. Relative/ friend interviews and blood and urine ethanol analyses were used to corroborate patients' reports. There were no significant differences among the groups in total abstinence, time to first drink, employment, or social stability. Among the patients who drank and had a complete set of assessment interviews, those in the 250-mg disulfiram group reported significantly fewer drinking days (49.0 ±8.4) than those in the 1-mg (75.4±11.9) or the no-disulfiram (86.5 ± 13.6) groups. There was a significant relationship between adherence to drug regimen and complete abstinence in all groups. We conclude that disulfiram may help reduce drinking frequency after relapse, but does not enhance counseling in aiding alcoholic patients to sustain continuous abstinence or delay the resumption of drinking. (JAMA1986;256:1449-1455)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Room, R., Babor, T., & Rehm, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17870-2 · Cited by 1,625
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923
Placebo interventions for all clinical conditions
Hróbjartsson, A., & Gøtzsche, P. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003974.pub3 · Cited by 777
Pathological gambling: Etiology, comorbidity, and treatment.
Petry, N. M. (2005) · doi:10.1037/10894-000 · Cited by 659
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Baucom, D. H., Shoham, V., Mueser, K. T., Daiuto, A. D., & Stickle, T. R. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.1.53 · Cited by 608
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review
Kranzler, H. R., & Soyka, M. (2018) · JAMA · doi:10.1001/jama.2018.11406 · Cited by 580
Myths about the treatment of addiction
O'Brien, C., & Thomas McLellan, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90409-2 · Cited by 512
Anticraving Medications for Relapse Prevention: A Possible New Class of Psychoactive Medications
O’Brien, C. P. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1423 · Cited by 405
The cost effectiveness of treatment for alcoholism: a first approximation
Holder, H., Longabaugh, R., Miller, W. R., & Rubonis, A. V. (1991) · Journal of Studies on Alcohol · doi:10.15288/jsa.1991.52.517 · Cited by 394
The Status of Disulfiram: A Half of a Century Later
Suh, J. J., Pettinati, H. M., Kampman, K. M., & O'Brien, C. P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222512.25649.08 · Cited by 382
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence
Mason, B. J., Salvato, F. R., Williams, L. D., Ritvo, E. C., & Cutler, R. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.719 · Cited by 271
Drug therapy for alcohol dependence
Swift, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401907 · Cited by 255
Naltrexone-induced alterations in human ethanol intoxication
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1463 · Cited by 254
Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes
Cramer, J., Rosenheck, R., Kirk, G., Krol, W., & Krystal, J. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.65269.x · Cited by 212
Glutamatergic targets for new alcohol medications
Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3226-2 · Cited by 197
Disulfiram treatment of alcoholism
Wright, C., & Moore, R. D. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90534-k · Cited by 183
Does disulfiram have a role in alcoholism treatment today?
FULLER, R. K., & GORDIS, E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00597.x · Cited by 182
Self-citationNaltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., & Rounsaville, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.016 · Cited by 177
Rediscovering fire: Small interventions, large effects.
Miller, W. R. (2000) · Psychology of Addictive Behaviors · doi:10.1037//0893-164x.14.1.6 · Cited by 173
The efficacy of disulfiram: a review of outcome studies
HUGHES, J. C., & COOK, C. C. H. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03370.x · Cited by 162
Carroll, K. M., & Rounsaville, B. J. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.3.333 · Cited by 155
A quantitative review of the ubiquitous relapse curve
Kirshenbaum, A. P., Olsen, D. M., & Bickel, W. K. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.04.001 · Cited by 125
Relapse Prevention and Maintaining Abstinence in Older Adults with Alcohol-Use Disorders
Barrick, C., & Connors, G. J. (2002) · Drugs & Aging · doi:10.2165/00002512-200219080-00004 · Cited by 126
Pharmacotherapy for alcohol dependence: status of current treatments
Franck, J., & Jayaram-Lindström, N. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.05.005 · Cited by 107
Gabapentin for the treatment of alcohol use disorder
Mason, B. J., Quello, S., & Shadan, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1417383 · Cited by 104
Packages of care for alcohol use disorders in low- and middle-income countries
Benegal, V., Chand, P. K., & Obot, I. S. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000170 · Cited by 94
Medications for substance use disorders
Douaihy, A. B., Kelly, T. M., & Sullivan, C. (2013) · Social Work in Public Health · doi:10.1080/19371918.2013.759031 · Cited by 93
Does disulfiram help to prevent relapse in alcohol abuse?
Brewer, C., Meyers, R. J., & Johnsen, J. (2000) · CNS Drugs · doi:10.2165/00023210-200014050-00001 · Cited by 92
Disulfiram Treatment for Alcoholism in Severe Mental Illness
Mueser, K. T., Noordsy, D. L., Fox, L., & Wolfe, R. (2003) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00652.x · Cited by 80
Intramuscular extended‐release naltrexone: current evidence
Gastfriend, D. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05900.x · Cited by 71
Traditional and Western Healing Practices for Alcoholism in American Indians and Alaska Natives
Abbott, P. J. (1998) · Substance Use & Misuse · doi:10.3109/10826089809059342 · Cited by 55
Family-involved alcoholism treatment. An update
O’Farrell, T. J., & Fals-Stewart, W. (2002) · Alcoholism · doi:10.1007/978-0-306-47193-3_19 · Cited by 48
Randomized open-label trial of baclofen for relapse prevention in alcohol dependence
Gupta, M., Verma, P., Rastogi, R., Arora, S., & Elwadhi, D. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1240797 · Cited by 26
Disulfiram in severe alcoholism–an open controlled study
Ulrichsen, J., Nielsen, M. K., & Ulrichsen, M. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039481003686180 · Cited by 26
Chen, P., Zhou, Y.-K., Han, C.-S., Chen, L.-J., Wang, Y.-M., Zhuang, Z.-M., Lin, S., Zhou, Y.-H., Jiang, J.-H., & Yang, R.-L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860225 · Cited by 25
Lu, X., Lin, B., Xu, N., Huang, H., Wang, Y., & Lin, J.-M. (2020) · Talanta · doi:10.1016/j.talanta.2020.120732 · Cited by 23
Weinshenker, D. (2010) · Nature Medicine · doi:10.1038/nm0910-969 · Cited by 15
Tang, C., Pang, X., Guo, Z., Guo, R., Liu, L., & Chen, X. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000317 · Cited by 14
Substance‐Related Disorders: Alcohol‐Related Disorders
Babor, T. F., Hernandez‐Avila, C. A., & Ungemack, J. A. (2015) · Psychiatry · doi:10.1002/9781118753378.ch72 · Cited by 8
Metadata
- Authors
- Fuller, R. K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1986-09-19
- Volume
- 256
- Issue
- 11
- Pages
- 1449
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4236852867
- Cited by
- 541
- References
- 0
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.